Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
U.S. Congress
521 - 540 of 995 Results
-
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Sen. Grassley Questions UVA Health On Findings From KHN Investigation
A letter from the Senate Finance Committee chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and prices.
-
KHN鈥檚 鈥榃hat The Health?鈥: Democrats Do Drugs (Prices)
House Democrats start legislative work on House Speaker Nancy Pelosi鈥檚 prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump鈥檚 health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists recommend their favorite health stories of the week.
-
KHN鈥檚 鈥榃hat The Health?鈥: Impeachment And The Health Agenda
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
At Raucous Hearing, No Unity On Vaping Issues
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
By Rachel Bluth -
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
-
KHN鈥檚 鈥榃hat The Health?鈥: Tennessee Seeks Medicaid Changes
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN鈥檚 Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book 鈥淭he Price We Pay鈥 about why health care costs so much.
-
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: Despite Booming Economy, Uninsured Rate Ticks Up
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau鈥檚 annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and 鈥渟urprise鈥 medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
Congress Rakes In Millions From Drugmakers
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
-
Legislation To End Surprise Medical Bills Has High Public Support 鈥 In Both Parties
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
-
States Pass Record Number Of Laws To Reel In Drug Prices
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Watch: Five Things To Know About Hunger Among America鈥檚 Aging
One out of every 13 seniors in America struggles to get enough food to eat while the federal program intended to help hasn鈥檛 kept pace with the graying population. KHN Midwest editor/correspondent Laura Ungar explains what you need to know about this largely hidden problem.
-
Trump Promises 鈥楶henomenal鈥 Health Plan. What Might That Mean?
In the background, advisers weigh the risks of rolling out a comprehensive health care proposal. Peering into the crystal ball, here鈥檚 a glimpse of what could be included in the GOP plan.
-
Starving Seniors: How America Fails To Feed Its Aging
One out of every 13 older Americans struggles to find enough food to eat while the federal program intended to help hasn鈥檛 kept pace with the graying population.
By Laura Ungar and Trudy Lieberman